MRVI
MRVI
US56600D1072
Maravai LifeSciences Holdings,
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.76B EUR
929.06M EUR
417.41M EUR
472.3M EUR
Enterprise Value
1.37B EUR
1.04B EUR
522.37M EUR
620.12M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-73.91x
--
--
--
Price to Sales
13.2x
4.45x
2.04x
3.4x
Price to Book
5.41x
4.54x
1.97x
2.22x
EV/Revenue
6.58x
4.96x
2.55x
4.46x
EV/EBITDA
-69.55x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-0.13%
-3.86%
-12.6%
-12.03%
ende